BioPh China 2017
June 20-22, 2017
A prefect blend of
Bio-solutions for phamra

Shanghai New International Exhibition Center (SNIEC)
  • CPhI China 2017
  • CPhI China 2017
  • CPhI China 2017

Alice Huang
Tel: +86 21 3339 2421

Asia's premier partnering event
for biopharmaceutical industry

BioPh China, as one of the most important exhibitions in CPhI China, attracts exhibitors worldwide in the fields of gene engineering, antibody engineering, biological information, biologicals, bioprocessing, cytobiology, clinical trials, drug delivery system, drug discovery, intellectual property, NT, personalized medicine, platform technology, Affairs, stem cell research, technology transfer, therapeutics, vaccine, etc.

It has established itself as an exclusive and leading industry platform in Asia for pharma, biotech, research institutes, investors and all other industry stakeholders to meet, network and discuss latest industry trends, partnership models and investment opportunities in Asia and global.

You can get access to pharmaceutical information directly all in one place.

There were 70,563 visitors in BioPh China 2016, and 10,944 of them were overseas visitors. 2,737 exhibitors created a unique one-stop platform for accelerating the development of pharma industry.

2016 Exhibitor List

Visitor Info 2015

Testimonials from Exhibitors

"BioPh China created great business opportunities for us. We developed many new clients on site of the show.

——International Business, Gene Science Pharmaceuticals"

"I really enjoyed to exhibit on BioPh China! It is a nice platform to meet decision makers from worldwide biopharmaceutical companies."

——Marketing, Shenzhen Mellow Hope Pharm Industrial

3rd China BioPh Outlook Summit & Precision Medicine Development Seminar

  • 110+Attendees
  • 90.6%Customers' Satisfaction
  • Company Type Proportion of Delegates
     57%pharmaceutical companies
    15%material & technology
    12%pharmaceutical investment
    9%consulting/ pharmaceutical technology
  • CPhI China 2014
  • CPhI China 2014
  • CPhI China 2014
  • CPhI China 2014

2016 Bioph Summit China Agenda

June 22, 2016, Wednesday Afternoon
SNIEC, Hall E2 Meeting Room M17



13:30- 14:00

The R&D Development of Antibody Drugs and China's Opportunities
Feng ZHOU, PhD., Product & Solution Specialist, Thomson Reuters


Companion Diagnostics and Bioanalytical in Biopharmaceutical Drug Development
Arron S. XU, Ph.D., Site Director, Intertek Champaign Laboratories


Update on Recent Progress of Precision Medicine at Livzon
Daotian FU, Ph.D., Vice President, Livzon Pharmaceutical Group Inc.


Therapeutic Antibody Screening and Evaluation
Bo CHEN, Ph.D., Founder, Shanghai Junshi Biosciences Co., Ltd.


Panel Discussion & Q&A: Future Trends on Biopharma Industry and The Development of Precision Medicine in China


End of the Seminar

Integrated Marketing Solutions

CPhI.cn——China's leading B2B Marketplace for Pharmaceutical IndustryMedia——Cooperation with Worldwide Authoritative Media
Email Blasting——More Than 6,949,673 Emails Sent to Professional Data Base Wechat——Mobile Marketing Promotions
Weibo——Weibo.com/cphi Interactive Activities though Instant Info SharingDirect Mailing——More Than 552,206 Mails Directly Sent to Industry Players
APP ——Cphi-app.com/chinaConferences——Best Practices Sharing & Case Studies Brainstorming

Media Partner